UBS Group AG - OCULUS INNOVATIVE SCIENCES I ownership

OCULUS INNOVATIVE SCIENCES I's ticker is OCLS and the CUSIP is 67575P207. A total of 28 filers reported holding OCULUS INNOVATIVE SCIENCES I in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OCULUS INNOVATIVE SCIENCES I
ValueSharesWeighting
Q1 2016$0
-100.0%
447
-75.9%
0.00%
Q4 2015$2,0001,856
+903.2%
0.00%
Q3 2015$0
-100.0%
185
-96.0%
0.00%
Q2 2015$6,000
-60.0%
4,671
-73.6%
0.00%
Q1 2015$15,000
+114.3%
17,687
+258.0%
0.00%
Q4 2014$7,0004,9400.00%
Other shareholders
OCULUS INNOVATIVE SCIENCES I shareholders Q1 2016
NameSharesValueWeighting ↓
B. Riley Wealth Advisors, Inc. 117,206$276,0000.04%
Madden Advisory Services, Inc. 475$1,0000.00%
UBS AG 1,930$5,0000.00%
DIMENSIONAL FUND ADVISORS LP 3,270$8,0000.00%
BANK OF AMERICA CORP /DE/ 4,225$10,0000.00%
WELLS FARGO & COMPANY/MN 6,371$15,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 24,497$57,0000.00%
AMERIPRISE FINANCIAL INC 142$00.00%
CITIGROUP INC 326$00.00%
MORGAN STANLEY 3,237$8,0000.00%
View complete list of OCULUS INNOVATIVE SCIENCES I shareholders